As a National Strategic Accounts Director, I focus on driving the adoption, utilization, and strategic positioning of innovative precision oncology diagnostics across complex healthcare systems, including academic medical centers, integrated delivery networks (IDNs), large dermatology and surgical oncology practices, and leading KOL institutions. I am passionate about building strategic partnerships that improve access to cutting-edge diagnostic solutions and support informed clinical decision-making.

Before transitioning to industry, I practiced as an oncology nurse and that experience continues to shape my perspective every day. Keeping the patient at the center of every decision remains my top priority, guiding my commitment to advancing innovations that improve outcomes while supporting clinicians in delivering the highest quality cancer care.